New stroke drug aims to cut disability in first 3 hours

NCT ID NCT07520565

Recruiting now Disease control Sponsor: Biocells (Beijing) Biotech Co.,Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial tests whether a single injection of BXOS110, given within 3 hours of an acute ischemic stroke, can reduce overall disability compared to a placebo. About 1112 adults aged 18-85 with moderate to severe stroke are being enrolled. The main goal is to see if more people achieve functional independence (mRS score 0-2) at 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BXOS110 injection
What this could lead to: If successful, this could provide a new treatment option to reduce long-term disability after a stroke.
What could go wrong: This is a single-dose study in a narrow 3-hour window, so many patients may not benefit. The trial is still recruiting, and results are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHAEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma in situ ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AIS

Contacts and locations

Locations

Beijing Tiantan Hospital , Capital Medical University
NOT_YET_RECRUITING

Beijing, China
Daqing Oilfield General Hospital
RECRUITING

Daqing, Heilongjiang, China
Harrison International Peace Hospital
RECRUITING

Hengshui, Hebei, China
Linfen Central Hospital
NOT_YET_RECRUITING

Linfen, Shanxi, China
Linyi People's Hospital
RECRUITING

Linyi, Shandong, China
MeiHekou Central Hospital
RECRUITING

Meihekou, Jilin, China
The Affiliated Hospital of Shenyang Medical College
RECRUITING

Shenyang, Liaoning, China
The First Affiliated Hospital of Nanyang Medicinal College
RECRUITING

Nanyang, Henan, China
Xianyang Hospital of Yan'an University
RECRUITING

Xianyang, Shaanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.